rss
Arch Dis Child doi:10.1136/adc.2006.114389

Absence of urinary opioid peptides in children with Autism

  1. Hilary Cass (cassh{at}gosh.nhs.uk)
  1. Great Ormond Street Hospital for Children, United Kingdom
    1. Paul Gringras (paulg{at}pobox.com)
    1. Evelina Children's Hospital, United Kingdom
      1. John March (john.march{at}moredun.ac.uk)
      1. Moredun Reseach Institute, United Kingdom
        1. Iain McKendrick (iain{at}bioss.ac.uk)
        1. Biomathmatic and Statistic Scotland, United Kingdom
          1. Anne E O'Hare (aohare{at}ed.ac.uk)
          1. University of Edinburgh, United Kingdom
            1. Lucy Owen (matt_lucy{at}blueyonder.co.uk)
            1. City University, United Kingdom
              1. Chris Pollin (chris.pollin{at}moredun.ac.uk)
              1. Moredun Research Institute, United Kingdom
                • Published Online First 12 March 2008

                Abstract

                Aim: It has been claimed for a number of years that the urine of children with autism contains exogenously derived opioid peptides. This finding is said to reflect a disturbance in the integrity of the gut epithelium, act as a diagnostic marker for autism and predict treatment response to a diet excluding gluten and casein. The aim of the present study was to determine whether exogenous or endogenous peptides were present either in the urine of children with autism, or control children.

                Design: Case-control study

                Setting: Cases were recruited from two tertiary referral centres specialising in autistic spectrum disorders whilst controls were recruited from and mainstream primary and secondary schools in the same geographical area.

                Participants: 65 boys with autism mean age 7:4 years (5-11) and 158 control boys mean age 7:8 years (4:2-11).

                Investigations: Urine samples were examined by High Pressure Liquid Chromatography (HPLC) and Matrix Assisted Laser Desorbtion Ionisation-Time of Flight Mass Spectroscopy (MALDI-TOF MS) for the presence of a number of putative opioid peptides.

                Outcomes: There were no significant differences between the HPLC urinary profiles of the children affected by autism and the typically developing controls. In those cases where HPLC showed peaks in the locations at which opioid peptides might be expected to be found., MALDI-TOF established that these peaks did not, in fact, represent opioid peptides at all.

                Conclusions: Given the lack of evidence for any opioid peptiduria in children with autism it can neither serve as a biomedical marker for autism, nor be employed to predict or monitor response to a casein and gluten exclusion diet.

                This Article

                1. Abstract
                2. PDF
                3. All versions of this article:
                  1. adc.2006.114389v1
                  2. 93/9/745most recent

                Responses

                1. Submit a response
                2. No responses published

                Register for free content

                The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

                ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

                Show me all >>